Equity Overview
Price & Market Data
Price: $4.75
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $53,128,728
Daily Volume: 0
Performance Metrics
1 Week: -5.00%
1 Month: -18.66%
3 Months: -25.90%
6 Months: -44.77%
1 Year: -61.57%
YTD: -31.16%
Company Details
Employees: 15
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.